Fresh Tracks Therapeutics Competitors and Similar CompaniesClear all
Fresh Tracks Therapeutics's competitors and similar companies include Alexion Pharmaceuticals.
 Fresh Tracks Therapeutics Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases. |  Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | |
Founding Date | Founding Date 2009 | Founding Date 1992 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boulder, US HQ Carmel, US | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more |
Employees | Employees 1338% decrease | Employees 10,6006% increase |
Valuation ($) | Valuation ($) 4.3 m | Valuation ($) 40.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $8m (FY, 2023) | Revenue (est.) $6.1b (FY, 2020) |
Net income | Net income ($5.7m) (FY, 2023) | Net income $603.4m (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Alexion Pharmaceuticals
HQ
Boston, US
Employees
10,600↑ 6% increase
Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View company